Molecular weight dependency of the acquired anticomplementary and anticoagulant activities of specifically substituted dextrans
- 1 July 1987
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 8 (4), 248-253
- https://doi.org/10.1016/0142-9612(87)90111-6
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Inhibition of human and guinea pig complement by heparin fractions differing in affinity for antithrombin III or in average molecular weightInternational Journal of Immunopharmacology, 1985
- Anticoagulant activity of dextran derivatives. Part II: Mechanism of thrombin inactivationBiomaterials, 1985
- Anticomplementary activity of dextran derivativesBiomaterials, 1985
- Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3bMolecular Immunology, 1983
- Anticoagulant activity of a synthetic heparinoid in relation to molecular weight and N‐sulfate contentJournal of Biomedical Materials Research, 1981
- Structural Determinants of the Capacity of Heparin to Inhibit the Formation of the Human Amplification C3 ConvertaseJCI Insight, 1981
- ANTICOAGULANT PROPERTIES OF HEPARIN AND HEPARIN FRACTIONSScandinavian Journal of Haematology, 1980
- Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.The Journal of Experimental Medicine, 1975
- Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serumImmunochemistry, 1966
- Anticomplementary Power of HeparinThe Journal of Infectious Diseases, 1929